Expanded Access Protocol Using CD3+/CD19+ Depleted PBSC
Expanded Access Protocol Using CD3+/CD19+ Depleted PBSC
Recruiting · NCT02356653 · Registry updated 2026-02-20Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Expanded Access Protocol Using CD3+/CD19+ Depleted PBSC | Bone Marrow Failure Disorders, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Hemic and Lymphatic Diseases, Neoplasms by Histologic Type, Nutritional and Metabolic Diseases, bone marrow disorder, hematologic disorder, hereditary disease, immune dysregulation-polyendocrinopathy-enteropathy-X-linked syndrome, immune system disorder, inborn error of immunity, inborn errors of metabolism, leukemia, metabolic disease, neoplasm | Recruiting | Early phase 1 | 2026-02-20 | NCT02356653 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Children's Hospital of Philadelphia | 215 |
1 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Children's Hospital of Philadelphia | Philadelphia | United States | 434 |